A phase II study of rapid cycling high dose testosterone (Bipolar Androgen Therapy) in men with metastatic castrate-resistant prostate cancer (mCRPC) resistant to abiraterone and/or enzalutamide

著录项

• 来源
  《European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)》 |2016年第null期|共1页
• 作者

  Denmeade S.; Antonarakis E.; Paller C.; Wang H.; Benjamin T.; Drake C.; Carducci M.; Eisenberger M.;

  展开▼
• 作者单位

  Johns Hopkins Univ Sch Med Oncol Baltimore MD USA;

  Johns Hopkins Univ Sch Med Oncol Baltimore MD USA;

  Johns Hopkins Univ Sch Med Oncol Baltimore MD USA;

  Johns Hopkins Univ Sch Med Oncol Baltimore MD USA;

  Johns Hopkins Univ Sch Med Oncol Baltimore MD USA;

  Johns Hopkins Univ Sch Med Oncol Baltimore MD USA;

  Johns Hopkins Univ Sch Med Oncol Baltimore MD USA;

  Johns Hopkins Univ Sch Med Oncol Baltimore MD USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词